Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (1)
Nature Communications (1)
Nature (1)
Nature Precedings (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Developmental biology
Diseases
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Angela Rago Clear advanced filters

Principles for the post-GWAS functional characterisation of risk loci

Alvaro Monteiro
Gerhard Coetzee
Ian Mills
ResearchOpen Access01 Nov 2010
Nature Precedings

P: 1
Reply to: Zebrafish prrx1a mutants have normal hearts

Noemi Castroviejo
Oscar H. Ocaña
M. Angela Nieto
Research23 Sept 2020
Nature

Volume: 585, P: E17-E19
A gene regulatory network to control EMT programs in development and disease

EMT is a developmental process that is aberrantly activated in metastasizing cancer cells, but how multiple transcription factors regulate EMT is unclear. Here, the authors uncover a gene regulatory network between Prrx1 and Snail1 that selects EMT mode in developing vertebrates and cancer cells.

Hassan Fazilaty
Luciano Rago
M. Angela Nieto
ResearchOpen Access11 Nov 2019
Nature Communications

Volume: 10, P: 1-16
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

Massimo Gentile
Fortunato Morabito
Valter Gattei
Research14 Apr 2020
Leukemia

Volume: 35, P: 235-238